US Stock MarketDetailed Quotes

Acurx Pharmaceuticals (ACXP)

Watchlist
  • 1.850
  • -0.060-3.14%
Close Feb 19 16:00 ET
4.71MMarket Cap-0.23P/E (TTM)

Acurx Pharmaceuticals (ACXP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-28.23%2.03M
-44.95%2.27M
-50.91%2.15M
-3.26%14.1M
-45.77%2.77M
-9.26%2.83M
19.66%4.12M
50.81%4.38M
20.55%14.58M
56.86%5.11M
Selling and administrative expenses
-1.81%1.6M
-24.01%1.75M
-45.08%1.55M
1.93%8.7M
-38.57%1.95M
-7.79%1.63M
34.42%2.3M
49.57%2.82M
16.29%8.53M
73.53%3.17M
-General and administrative expense
-1.81%1.6M
-24.01%1.75M
-45.08%1.55M
1.93%8.7M
-38.57%1.95M
-7.79%1.63M
34.42%2.3M
49.57%2.82M
16.29%8.53M
73.53%3.17M
Research and development costs
-64.14%429.69K
-71.29%524.21K
-61.49%598.8K
-10.59%5.4M
-57.53%825.06K
-11.18%1.2M
5.14%1.83M
53.12%1.56M
27.12%6.04M
35.60%1.94M
Operating profit
28.23%-2.03M
44.95%-2.27M
50.91%-2.15M
3.26%-14.1M
45.77%-2.77M
9.26%-2.83M
-19.66%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
Net non-operating interest income expense
618.08%35.91K
2,892.84%23.4K
5K
782
Non-operating interest income
618.08%35.91K
2,892.84%23.4K
----
----
----
--5K
--782
----
----
----
Other net income (expense)
Income before tax
29.37%-1.99M
45.50%-2.25M
50.91%-2.15M
3.26%-14.1M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
Income tax
Net income
29.37%-1.99M
45.50%-2.25M
50.91%-2.15M
3.26%-14.1M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
Net income continuous Operations
29.37%-1.99M
45.50%-2.25M
50.91%-2.15M
3.26%-14.1M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
Minority interest income
Net income attributable to the parent company
29.37%-1.99M
45.50%-2.25M
50.91%-2.15M
3.26%-14.1M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.37%-1.99M
45.50%-2.25M
50.91%-2.15M
3.26%-14.1M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
Basic earnings per share
64.35%-1.23
63.72%-1.89
60.71%-2.2
24.35%-17.4
58.29%-3.17
28.13%-3.45
6.96%-5.21
-12.00%-5.6
-2.68%-23
-35.71%-7.6
Diluted earnings per share
64.35%-1.23
63.72%-1.89
60.71%-2.2
24.35%-17.4
58.29%-3.17
28.13%-3.45
6.96%-5.21
-12.00%-5.6
-2.68%-23
-35.71%-7.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -28.23%2.03M-44.95%2.27M-50.91%2.15M-3.26%14.1M-45.77%2.77M-9.26%2.83M19.66%4.12M50.81%4.38M20.55%14.58M56.86%5.11M
Selling and administrative expenses -1.81%1.6M-24.01%1.75M-45.08%1.55M1.93%8.7M-38.57%1.95M-7.79%1.63M34.42%2.3M49.57%2.82M16.29%8.53M73.53%3.17M
-General and administrative expense -1.81%1.6M-24.01%1.75M-45.08%1.55M1.93%8.7M-38.57%1.95M-7.79%1.63M34.42%2.3M49.57%2.82M16.29%8.53M73.53%3.17M
Research and development costs -64.14%429.69K-71.29%524.21K-61.49%598.8K-10.59%5.4M-57.53%825.06K-11.18%1.2M5.14%1.83M53.12%1.56M27.12%6.04M35.60%1.94M
Operating profit 28.23%-2.03M44.95%-2.27M50.91%-2.15M3.26%-14.1M45.77%-2.77M9.26%-2.83M-19.66%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M
Net non-operating interest income expense 618.08%35.91K2,892.84%23.4K5K782
Non-operating interest income 618.08%35.91K2,892.84%23.4K--------------5K--782------------
Other net income (expense)
Income before tax 29.37%-1.99M45.50%-2.25M50.91%-2.15M3.26%-14.1M45.61%-2.78M9.42%-2.82M-19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M
Income tax
Net income 29.37%-1.99M45.50%-2.25M50.91%-2.15M3.26%-14.1M45.61%-2.78M9.42%-2.82M-19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M
Net income continuous Operations 29.37%-1.99M45.50%-2.25M50.91%-2.15M3.26%-14.1M45.61%-2.78M9.42%-2.82M-19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M
Minority interest income
Net income attributable to the parent company 29.37%-1.99M45.50%-2.25M50.91%-2.15M3.26%-14.1M45.61%-2.78M9.42%-2.82M-19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.37%-1.99M45.50%-2.25M50.91%-2.15M3.26%-14.1M45.61%-2.78M9.42%-2.82M-19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M
Basic earnings per share 64.35%-1.2363.72%-1.8960.71%-2.224.35%-17.458.29%-3.1728.13%-3.456.96%-5.21-12.00%-5.6-2.68%-23-35.71%-7.6
Diluted earnings per share 64.35%-1.2363.72%-1.8960.71%-2.224.35%-17.458.29%-3.1728.13%-3.456.96%-5.21-12.00%-5.6-2.68%-23-35.71%-7.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Trump cheers on towards 100,000! Will the Dow continue its surge after breaking through 50,000 point
On February 10 Eastern Time, the Dow Jones Industrial Average hit another all-time high! Previously, on February 6, the Dow surpassed the hi Show More